Christopher Michael Ryan - 21 Jun 2022 Form 4 Insider Report for Gevo, Inc. (GEVO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Jun 2022, 17:50:40 UTC
Prior SEC filing
24 Aug 2021
Next SEC filing
08 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Geoffrey T. Williams, Attorney-in-Fact

Key filing fact

Christopher Michael Ryan filed Form 4 for Gevo, Inc. (GEVO) on 23 Jun 2022.

Key facts

  • This page summarizes Christopher Michael Ryan's Form 4 filing for Gevo, Inc. (GEVO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Jun 2022, 17:50.

Change

  • Previous filing in this sequence was filed on 24 Aug 2021.
  • Current net transaction value: -$131,997.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GEVO transaction

Common Stock

Sale

Transaction value
$131,997
Shares
-51,049
Change %
-5%
Price
$2.59
Shares after
960,450
Date
21 Jun 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .